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Substituted g-lactams are important heterocyclic motifs found in various biologically active compounds and marketed drugs, such as 
glimepiride, doxapram, and levetiracetam. Among available methods for the synthesis of substituted g-lactams, the addition of 
nucleophiles to N-acyliminium ions remains the most widely utilized approach. Even though hydroxylactams are important precursors of 
cyclic N-acyliminium ions, few approaches for their synthesis have been reported so far. By implementing a reductive cyclization 
reaction, linear L-malic acid derivatives were rapidly converted into cyclic N-acyliminium ions. Under the optimized conditions, entailing 
the use of HFIP as solvent, both electron-rich and electron-deficient boronic acids were successfully added to a range of cyclic 
N-acyliminium ions, thereby obtaining a collection of pharmaceutically relevant substituted g-lactams. 
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In the year 2012, cancer was a leading cause of death with 14.1 million new cases and a mortality of 8.2 million people worldwide.
[1]
 
This fact and the currently limited therapeutic regimen shows up the necessity to find novel substances for cancer treatment.
[2,3]
 Some 
naturally occurring benzo[c]phenanthridines were found to possess promising cytotoxic properties,
[4]
 initiating the development of 
synthetic derivatives of this class. Since all common routes to gain these heterocycles were complex and multistep, it was necessary to 
establish a new efficient synthetic procedure. 
We herein report a facile and efficient synthetic access to 11-substituted benzo[c]phenanthridines and structurally related 
substance classes.
[5]
 The high variability of the reaction is not limited to the diversity of the substitution pattern in position 11, it is 
further possible to vary the quantity and position of nitrogen atoms by utilizing differently substituted o-methyl-heteroarylnitrile 
derivatives. With this simple base-catalyzed one-pot reaction followed by an optional dehydrogenation (Scheme 1) we were able to 
build up a large library of 11-substituted heterocyclic scaffolds, mainly unknown to literature.
[5,6]
 Depending on the electronic structure 
of the used nitrile building block, either the 6-amino-dihydropyridophenanthrolines or the dihydro-11H-pyrido-azacarbazoles can be 
observed as main products. In the NCI-60 DTP Human Tumor Cell Line Screen (National Cancer Institute, Maryland, USA) various 
derivatives exhibited high antitumor activities.
[7]
 Moreover studies regarding physicochemical properties revealed an improved water 
solubility at physiological pH value and a reduced lipophilicity in comparison to the closely related carbon-analogous 
benzo[c]phenanthridines.
[6]
 
The great number of derivatives of these new substance classes and a facile possibility for functionalization in connection with 
strong cytotoxic properties emphasize the broad range of applicability and the importance of this synthetic procedure. 
 
 
 
Scheme 1. Schematically illustrates synthetic route to 6-amino-pyridophenanthrolines and 11H-pyridoazacarbazoles with different 
quantity and position of nitrogen atoms. 
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